Testing JNJ-42756493 In Combination With Dexamethasone in Multiple Myeloma That Came Back After a Period of Improvement
- Status
- TERMINATED
- Phase
- PHASE2
Clinical Trials Related to Dexamethasone
Related studies linked through entity extraction aliases.
A Study to Evaluate Dara-CyBorD in Previously Untreated and Relapsed Subjects With Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
A Study of Venetoclax and ABBV-838 Combination Therapy With Dexamethasone in Participants With Multiple Myeloma Whose Cancer Has Come Back or Had No Response to Recent Cancer Treatment
- Status
- WITHDRAWN
- Phase
- PHASE1
Treatment of Peri-calcification Edema in Neurocysticercosis (NCC)
- Status
- TERMINATED
- Phase
- PHASE2/PHASE3
Phase 1b Study Evaluating OPomD in Relapsed or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE1
Mgt of Chronic Subdural Hematoma Using Dexamethasone
- Status
- UNKNOWN
- Phase
- PHASE2/PHASE3
High Dose Carfilzomib for Newly Diagnosed Myeloma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Effects and Dose Response of Dexamethasone on Intercostal Blocks With Bupivicaine in Post Thoracic Surgery Patients
- Status
- UNKNOWN
- Phase
- PHASE3
Study Testing Radium-223 Dichloride in Relapsed Multiple Myeloma
- Status
- TERMINATED
- Phase
- PHASE1/PHASE2
Ixazomib Citrate, Lenalidomide, and Dexamethasone in Treating Patients With POEMS Syndrome
- Status
- COMPLETED
- Phase
- EARLY_PHASE1
PEG-ASP+Gemoxd vs. PEG-ASP+CHOP as First-line Chemotherapy to Treatment NK/T-cell Lymphoma With Early Stage
- Status
- UNKNOWN
- Phase
- PHASE2
A Study of JNJ-54767414 (Daratumumab) in Combination With Lenalidomide and Dexamethasone in Japanese Participants With Previously Untreated Multiple Myeloma Who Are Ineligible for High-dose Therapy and Autologous Stem Cell Transplantation
- Status
- COMPLETED
- Phase
- PHASE1
A Study of Ixazomib Plus Lenalidomide and Dexamethasone in Adult Japanese Participants With Relapsed and/or Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Trial of Combination of Ixazomib and Lenalidomide and Dexamethasone in Smoldering Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Efficacy and Safety of Pomalidomide in Combination With Low-dose Dexamethasone in Chinese Patients With Relapsed and Refractory Multiple Myeloma
- Status
- UNKNOWN
- Phase
- PHASE3
L-DEP as an Initial Treatment for EBV-HLH
- Status
- UNKNOWN
- Phase
- PHASE3
Pembrolizumab + Lenalidomide Post Autologous Stem Cell Transplant (ASCT) in High-risk Multiple Myeloma (MM)
- Status
- TERMINATED
- Phase
- PHASE2
Perineural Versus Systemic Dexamethasone to Prolong Regional Anesthesia in Front Foot Surgery
- Status
- COMPLETED
- Phase
- PHASE3
A Phase II Trial If Nivolumab, Lenalidomide and Dexamethasone in High Risk Smoldering Myeloma
- Status
- COMPLETED
- Phase
- PHASE2
Study of Ibrutinib in Combination With Bortezomib and Dexamethasone in Subjects With Relapsed/Relapsed and Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- PHASE2